Related references
Note: Only part of the references are listed.The leukotriene signaling pathway: a druggable target in Alzheimer's disease
Johanna Michael et al.
DRUG DISCOVERY TODAY (2019)
Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug
Paolo Gelosa et al.
PHARMACOLOGICAL RESEARCH (2019)
The Role of Inflammation in Depression and Fatigue
Chieh-Hsin Lee et al.
FRONTIERS IN IMMUNOLOGY (2019)
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Marie-Laure Arotcarena et al.
CELLS (2019)
Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing
Qingyun Li et al.
NEURON (2019)
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Aleksandra Deczkowska et al.
CELL (2018)
CysLTR1 Blockage Ameliorates Liver Injury Caused by Aluminum-Overload via PI3K/AKT/mTOR-Mediated Autophagy Activation in Vivo and in Vitro
Congli Hu et al.
MOLECULAR PHARMACEUTICS (2018)
Treatment of Autonomic Dysfunction in Parkinson Disease and Other Synucleinopathies
Jose-Alberto Palma et al.
MOVEMENT DISORDERS (2018)
Lewy Bodies and the Mechanisms of Neuronal Cell Death in Parkinson's Disease and Dementia with Lewy Bodies
John H. T. Power et al.
BRAIN PATHOLOGY (2017)
Non-motor features of Parkinson disease
Anthony H. V. Schapira et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Fiona M. Menzies et al.
NEURON (2017)
Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease
Hannah Jang et al.
NEUROREPORT (2017)
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease
Shuchi Mittal et al.
SCIENCE (2017)
Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified
Bjorn Grinde et al.
IMMUNITY & AGEING (2017)
New Therapeutic Strategies for Lewy Body Dementias
Latha Velayudhan et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Microglia in dementia with Lewy bodies
Wolfgang J. Streit et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Montelukast ameliorates streptozotocin-induced cognitive impairment and neurotoxicity in mice
Chun Teng Zhang et al.
NEUROTOXICOLOGY (2016)
Montelukast, current indications and prospective future applications
Naim Kittana et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2016)
TSPO imaging in parkinsonian disorders
Alexander Gerhard
CLINICAL AND TRANSLATIONAL IMAGING (2016)
The L-type calcium channel Cav1.3 is required for proper hippocampal neurogenesis and cognitive functions
Julia Marschallinger et al.
CELL CALCIUM (2015)
Neuroinflammation in Lewy body dementia
Ajenthan Surendranathan et al.
PARKINSONISM & RELATED DISORDERS (2015)
Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
Julia Marschallinger et al.
NATURE COMMUNICATIONS (2015)
Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases
Haijian Wu et al.
MOLECULAR NEUROBIOLOGY (2015)
Gene-Wise Association of Variants in Four Lysosomal Storage Disorder Genes in Neuropathologically Confirmed Lewy Body Disease
Lorraine N. Clark et al.
PLOS ONE (2015)
Microglial dysfunction in brain aging and Alzheimer's disease
Kira Irving Mosher et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Chaperone-mediated autophagy: roles in disease and aging
Ana Maria Cuervo et al.
CELL RESEARCH (2014)
Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease
P. F. Giannopoulos et al.
MOLECULAR PSYCHIATRY (2014)
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2014)
Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats
Ihab T. Abdel-Raheem et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice
Antonio Di Meco et al.
NEUROBIOLOGY OF AGING (2014)
Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling
Jin'e Lai et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Adult Hippocampal Neurogenesis in Parkinson's Disease: Impact on Neuronal Survival and Plasticity
Martin Regensburger et al.
NEURAL PLASTICITY (2014)
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment
Daniel Lindqvist et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats
Fadhil G. Al-Amran et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2013)
Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited -synuclein accumulation and age-dependent sensorimotor deficits
Patrick J. Schultheis et al.
HUMAN MOLECULAR GENETICS (2013)
Protection of dopaminergic neurons by 5-lipoxygenase inhibitor
Kai-Hsiang Kang et al.
NEUROPHARMACOLOGY (2013)
DIFFERENTIAL CONTRIBUTION OF LIPDXYGENASE ISOZYMES TO NIGROSTRIATAL VULNERABILITY
V. P. Chou et al.
NEUROSCIENCE (2013)
Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a Mouse Model of Alzheimer's Disease with Plaques and Tangles
Jin Chu et al.
PLOS ONE (2013)
Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis
A. Scaife et al.
RESPIRATORY MEDICINE (2013)
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle
Stefano Fogli et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of alzheimer disease
Jin Chu et al.
ANNALS OF NEUROLOGY (2012)
Autophagy in Dementias
Christine Lund Kragh et al.
BRAIN PATHOLOGY (2012)
Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production
Mai M. Helmy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
An Automated Method to Quantify Microglia Morphology and Application to Monitor Activation State Longitudinally In Vivo
Cleopatra Kozlowski et al.
PLOS ONE (2012)
Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum
Daniel Lindqvist et al.
PLOS ONE (2012)
Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats
Anil Kumar et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Pharmacologic Blockade of 5-Lipoxygenase Improves the Amyloidotic Phenotype of an Alzheimer's Disease Transgenic Mouse Model Involvement of γ-Secretase
Jin Chu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Inhibition of Leukotriene Receptors Boosts Neural Progenitor Proliferation
Christophe Huber et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
A Cytosolic Phospholipase A2-Initiated Lipid Mediator Pathway Induces Autophagy in Macrophages
Hai-Yan Qi et al.
JOURNAL OF IMMUNOLOGY (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
The Effects of Montelukast on Antioxidant Enzymes and Proinflammatory Cytokines on the Heart, Liver, Lungs, and Kidneys in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis
Ali Kagan Coskun et al.
THESCIENTIFICWORLDJOURNAL (2011)
Pathogenic Lysosomal Depletion in Parkinson's Disease
Benjamin Dehay et al.
JOURNAL OF NEUROSCIENCE (2010)
PROTECTIVE EFFECT OF MONTELUKAST AGAINST QUINOLINIC ACID/MALONIC ACID INDUCED NEUROTOXICITY: POSSIBLE BEHAVIORAL, BIOCHEMICAL, MITOCHONDRIAL AND TUMOR NECROSIS FACTOR-α LEVEL ALTERATIONS IN RATS
H. Kalonia et al.
NEUROSCIENCE (2010)
Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model
Song Ge et al.
ATHEROSCLEROSIS (2009)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Effects of zileuton and montelukast in mouse experimental spinal cord injury
T. Genovese et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Montelukast inhibits tumour necrosis factor-α-mediated interleukin-8 expression through inhibition of nuclear factor-κB p65-associated histone acetyltransferase activity
F. Tahan et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease
Omidreza Firuzi et al.
FASEB JOURNAL (2008)
The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics
Hooman Allayee et al.
CHEST (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis
I Stelmach et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Effect of montelukast on nuclear factor κB activation and proinflammatory molecules
S Maeba et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors
WP Zhang et al.
NEUROSCIENCE LETTERS (2004)
Human wild-type α-synuclein impairs neurogenesis
B Winner et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Share Paper
